The US is the bigger Decentralized Clinical Trials(DCTs) market: $689 Mn against $132 Mn in 2023, about 5.2 times as large.
China grows faster: 16.3% a year, against 12.8%. The gap still grows from $557 Mn to $1.7 Bn by 2033.
Clinical research: 986 active trials in the US, 617 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $689 Mn | $132 Mn |
| Market size, 2033 projected | $2.3 Bn | $597 Mn |
| Growth a year (CAGR) | 12.8% | 16.3% |
| Money added, 2023–2033 | $1.6 Bn | $465 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $2.02 | $0.09 |
| Active clinical trials | 986 | 617 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Decentralized Clinical Trials(DCTs), US or China?
The US is the bigger Decentralized Clinical Trials(DCTs) market: $689 Mn against $132 Mn in 2023, about 5.2 times as large.
Which grows faster in Decentralized Clinical Trials(DCTs), US or China?
China grows faster: 16.3% a year, against 12.8%. The gap still grows from $557 Mn to $1.7 Bn by 2033.
More Decentralized Clinical Trials(DCTs) comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.